FDA’s drug quality report notes ‘significant’ uptick in inspections since pandemic
Regulatory NewsJoanne S. Eglovitch
CDERComplianceGMPPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)